Piper Jaffray Cuts Price Target on Sequenom (SQNM) as Guidance is Below Street

Go back to Piper Jaffray Cuts Price Target on Sequenom (SQNM) as Guidance is Below Street

Sequenom Announces Contract with Anthem BlueCross

March 2, 2016 4:39 PM EST

SAN DIEGO, March 2, 2016 /PRNewswire/ -- Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced the completion of an agreement with Anthem BlueCross.  The agreement provides in-network coverage for Anthem's California customers for Sequenom Laboratories' noninvasive prenatal tests in both high and average risk pregnancies, beginning March 1, 2016. 

"We are excited to be contracted with Anthem BlueCross," said Dr. Dirk van den Boom,... More

Sequenom, Inc. Reports 2015 Financial Results

March 2, 2016 4:05 PM EST

SAN DIEGO, March 2, 2016 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today reported results for the fourth quarter and full year 2015.

Fourth Quarter and Full Year 2015 Highlights:

Fourth quarter total accessions of 42,200, up from 41,000 in Q3 2015 Fourth quarter noninvasive prenatal test (NIPT) accessions of 37,300, up from 35,500 in Q3 2015 Total accessions of 180,400... More